FORM 6-K
 

 

SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549

 

Report of Foreign Issuer

 

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
 


For period ending March 2010
 

GlaxoSmithKline plc
(Name of registrant)
 
 

 

980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)
 
 

Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F
 
 

Form 20-F x Form 40-F
 

 --

Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
 
 
Yes No x
  --

 

 

ANNUAL INFORMATION UPDATE FOR GLAXOSMITHKLINE PLC
FOR THE 12 MONTHS UP TO 25 MARCH 2010
 
 
In accordance with the requirements of Prospectus Rules PR 5.2.1R please find below an Annual Information Update for GlaxoSmithKline plc ("The Company"). The information referred to in this update was up to date at the time the information was published, but some information may now be out of date.
 
To avoid an unnecessarily lengthy document the following are summaries of the information and documents published or made available to the public, by the Company throughout the twelve months ended 25 March 2010.
 
 
1.   Announcements made via RNS, a Regulatory Information Service.
 
The announcements listed below were published on the London Stock Exchange via RNS, a Regulatory Information Service and can be obtained from their website
www.londonstockexchange.com
  or the Company's website
www.gsk.com
.
 

22/03/2010
Director/PDMR Shareholding
22/03/2010
Notifiable Share Interest in OctoPlus N.V.
16/03/2010
Director/PDMR Shareholding
16/03/2010
Notice of AGM
12/03/2010
Succession Planning for Vaccine business
12/03/2010
Notifiable share interest in Maxygen, Inc.
10/03/2010
Director/PDMR Shareholding
09/03/2010
Director/PDMR Shareholding
01/03/2010
GSK files its Annual Report 2009 on Form 20-F
01/03/2010
Total Voting Rights
25/02/2010
Annual Report and Accounts
25/02/2010
Director/PDMR Shareholding
24/02/2010
Director/PDMR Shareholding
24/02/2010
Director/PDMR Shareholding
24/02/2010
Director/PDMR Shareholding
23/02/2010
Director/PDMR Shareholding
23/02/2010
Director/PDMR Shareholding
22/02/2010
Director/PDMR Shareholding
22/02/2010
Director/PDMR Shareholding
22/02/2010
Director/PDMR Shareholding
19/02/2010
Statement on FDA's proposed Advair label revisions
12/02/2010
Director/PDMR Shareholding
10/02/2010
Director/PDMR Shareholding
09/02/2010
Director/PDMR Shareholding
05/02/2010
Director/PDMR Shareholding
05/02/2010
Director/PDMR Shareholding
04/02/2010
GSK amends emerging market data in 2009 results
04/02/2010
Final Results - Part 3
04/02/2010
Final Results - Part 2
04/02/2010
Final Results - Part 1
04/02/2010
Final Results - Part 4
02/02/2010
Total Voting Rights
29/01/2010
Director/PDMR Shareholding
26/01/2010
Director/PDMR Shareholding
20/01/2010
Director/PDMR Shareholding
19/01/2010
Director/PDMR Shareholding
15/01/2010
Government Orders for Pandemic
13/01/2010
Director/PDMR Shareholding
13/01/2010
Director/PDMR Shareholding
12/01/2010
Director/PDMR Shareholding
12/01/2010
Director/PDMR Shareholding
12/01/2010
Director/PDMR Shareholding
11/01/2010
Director/PDMR Shareholding
11/01/2010
Director/PDMR Shareholding
11/01/2010
Director/PDMR Shareholding
08/01/2010
Director/PDMR Shareholding (Replacement)
05/01/2010
Director/PDMR Shareholding
05/01/2010
Director/PDMR Shareholding
05/01/2010
Notifiable Share Interest in Maxygen, Inc.
04/01/2010
Total Voting Rights
21/12/2009
Director/PDMR Shareholding
18/12/2009
Director/PDMR Shareholding
11/12/2009
Director/PDMR Shareholding
07/12/2009
Notifiable Share Interest in Addex Pharmaceuticals
04/12/2009
Holding(s) in Company
01/12/2009
Total Voting Rights
01/12/2009
GSK completes extension of strategic collaboration
18/11/2009
Blocklisting Interim Review
11/11/2009
Director/PDMR Shareholding
11/11/2009
Director/PDMR Shareholding
09/11/2009
Director/PDMR Shareholding
05/11/2009
Director/PDMR Shareholding
05/11/2009
Director/PDMR Shareholding
04/11/2009
Director/PDMR Shareholding
02/11/2009
Director/PDMR Shareholding
02/11/2009
Total Voting Rights
02/11/2009
Phase 3 Trial Results BENLYSTA
28/10/2009
Director/PDMR Shareholding - Amendment
28/10/2009
3rd Quarter Results - Part 2
28/10/2009
3rd Quarter Results - Part 1
28/10/2009
3rd Quarter Results - Part 3
28/10/2009
3rd Quarter Results - Part 4
20/10/2009
Director/PDMR Shareholding
20/10/2009
Director/PDMR Shareholding
20/10/2009
Director/PDMR Shareholding
20/10/2009
Director/PDMR Shareholding
16/10/2009
FDA approves Cervarix
16/10/2009
Director/PDMR Shareholding
12/10/2009
Director/PDMR Shareholding
12/10/2009
Director/PDMR Shareholding
12/10/2009
Director/PDMR Shareholding
12/10/2009
Director/PDMR Shareholding
06/10/2009
Director/PDMR Shareholding
06/10/2009
GSK Expands Presence in China via Joint Venture
06/10/2009
H1N1 2009 vaccine update
02/10/2009
Director/PDMR Shareholding
02/10/2009
Changes to Board Committee
01/10/2009
Total Voting Rights
22/09/2009
Director/PDMR Shareholding
18/09/2009
Notifiable share interest in Algeta ASA
11/09/2009
Director/PDMR Shareholding
01/09/2009
Director/PDMR Shareholding
01/09/2009
Total Voting Rights
21/08/2009
Vernalis PLC Holding(s) in Company
21/08/2009
Holding(s) in Company
20/08/2009
Vernalis PLC Admission of Subscription Shares to GSK
13/08/2009
Director/PDMR Shareholding
12/08/2009
Director/PDMR Shareholding
11/08/2009
Director/PDMR Shareholding
06/08/2009
Director/PDMR Shareholding
06/08/2009
Director/PDMR Shareholding
06/08/2009
Vernalis PLC Vernalis and GlaxoSmithKline enter collaboration
06/08/2009
Interest in shares in Vernalis plc
04/08/2009
Government orders for H1N1 vaccine
03/08/2009
Director/PDMR Shareholding
03/08/2009
Total Voting Rights
30/07/2009
Publication of Registration Document
30/07/2009
Publication of Prospectus
23/07/2009
Director/PDMR Shareholding
22/07/2009
Half Yearly Report - Part 3
22/07/2009
Half Yearly Report - Part 1
22/07/2009
Half Yearly Report - Part 2
22/07/2009
Half Yearly Report - Part 4
20/07/2009
Director/PDMR Shareholding
17/07/2009
Director/PDMR Shareholding
15/07/2009
Director/PDMR Shareholding
14/07/2009
Director/PDMR Shareholding
14/07/2009
Director/PDMR Shareholding
14/07/2009
Director/PDMR Shareholding
10/07/2009
Director/PDMR Shareholding
10/07/2009
Director/PDMR Shareholding
10/07/2009
Changes to Board Committees
09/07/2009
Office of Fair Trade Merger Update
07/07/2009
Director/PDMR Shareholding
02/07/2009
Portfolio extended in Middle East and North Africa
01/07/2009
Director/PDMR Shareholding
01/07/2009
Total Voting Rights
11/06/2009
Director/PDMR Shareholding
10/06/2009
Director/PDMR Shareholding
09/06/2009
Neptunus Joint Venture
02/06/2009
Director/PDMR Shareholding
01/06/2009
Total Voting Rights
29/05/2009
Director/PDMR Shareholding
27/05/2009
Office of Fair Trade Merger Update
21/05/2009
AGM - Special Business
20/05/2009
Result of AGM
19/05/2009
Director/PDMR Shareholding
15/05/2009
Director/PDMR Shareholding
15/05/2009
A (H1N1) Influenza Vaccine
13/05/2009
Director/PDMR Shareholding
12/05/2009
GSK extends Strategic Collabo
ration
11/05/2009
Director/PDMR Shareholding
11/05/2009
Director/PDMR Shareholding
11/05/2009
Director/PDMR Shareholding
11/05/2009
Director/PDMR Shareholding
11/05/2009
Blocklisting Interim Review
08/05/2009
Director/PDMR Shareholding
06/05/2009
Wellbutrin XL US divestiture
05/05/2009
Director/PDMR Shareholding
01/05/2009
Total Voting Rights
27/04/2009
REDUCE Topline Results
22/04/2009
1st Quarter Results - Part 3
22/04/2009
1st Quarter Results - Part 1
22/04/2009
1st Quarter Results - Part 2
20/04/2009
GSK to acquire Stiefel Labora
tories
16/04/2009
Director/PDMR Shareholding
16/04/2009
Director/PDMR Shareholding
16/04/2009
GSK Specialist HIV Company
14/04/2009
Director/PDMR Shareholding
14/04/2009
Director/PDMR Shareholding
07/04/2009
Director/PDMR Shareholding
06/04/2009
Total Voting Rights
01/04/2009
Director/PDMR Shareholding
30/03/2009
U.S. FDA Filing-Cervarix
27/03/2009
Changes to Board Committees
27/03/2009
Annual Information Update


                        
2.   Documents filed at Companies House
 
All documents listed below were filed with the Registrar of Companies in England and Wales on or around the dates indicated, and can be obtained from Companies House via their website
www.companieshouse.gov.uk
 

Date
Document Type
Description of Document Filed
11/03/2010
SH01
Statement of Capital
01/03/2010
SH01
Statement of Capital
11/02/2010
SH01
Statement of Capital
03/02/2010
SH01
Statement of Capital
16/01/2010
SH01
Statement of Capital
06/01/2010
SH01
Statement of Capital
22/12/2009
SH01
Statement of Capital
03/12/2009
SH01
Statement of Capital
18/11/2009
SH01
Statement of Capital
18/11/2009
SH01
Statement of Capital
02/11/2009
AR01
Annual Return
25/10/2009
SH01
Statement of Capital
25/10/2009
SH01
Statement of Capital
25/10/2009
SH01
Statement of Capital
25/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
24/10/2009
SH01
Statement of Capital
16/10/2009
AD03
Register Moved to Sail Address
16/10/2009
AD02
Sail Address
08/10/2009
SH01
Statement of Capital
27/09/2009
88(2)
Return of Allotment of Shares
27/09/2009
88(2)
Return of Allotment of Shares
27/09/2009
88(2)
Return of Allotment of Shares
27/09/2009
88(2)
Return of Allotment of Shares
27/09/2009
88(2)
Return of Allotment of Shares
23/09/2009
88(2)
Return of Allotment of Shares
23/09/2009
88(2)
Return of Allotment of Shares
14/09/2009
88(2)
Return of Allotment of Shares
14/09/2009
88(2)
Return of Allotment of Shares
26/08/2009
88(2)
Return of Allotment of Shares
19/08/2009
88(2)
Return of Allotment of Shares
19/08/2009
88(2)
Return of Allotment of Shares
19/08/2009
88(2)
Return of Allotment of Shares
12/08/2009
88(2)
Return of Allotment of Shares
12/08/2009
88(2)
Return of Allotment of Shares
30/07/2009
88(2)
Return of Allotment of Shares
24/07/2009
88(2)
Return of Allotment of Shares
24/07/2009
88(2)
Return of Allotment of Shares
24/07/2009
88(2)
Return of Allotment of Shares
24/07/2009
88(2)
Return of Allotment of Shares
24/07/2009
88(2)
Return of Allotment of Shares
24/07/2009
88(2)
Return of Allotment of Shares
24/07/2009
88(2)
Return of Allotment of Shares
24/07/2009
88(2)
Return of Allotment of Shares
24/07/2009
88(2)
Return of Allotment of Shares
24/07/2009
88(2)
Return of Allotment of Shares
24/07/2009
88(2)
Return of Allotment of Shares
24/07/2009
88(2)
Return of Allotment of Shares
24/06/2009
288a
Director Appointment
05/06/2009
RES10
AGM Special Business
28/05/2009
288b
Resignation of Director
28/05/2009
288b
Resignation of Director
26/05/2009
88(2)
Return of Allotment of Shares
26/05/2009
88(2)
Return of Allotment of Shares
05/05/2009
88(2)
Return of Allotment of Shares
05/05/2009
88(2)
Return of Allotment of Shares
05/05/2009
88(2)
Return of Allotment of Shares
05/05/2009
88(2)
Return of Allotment of Shares
05/05/2009
88(2)
Return of Allotment of Shares
05/05/2009
88(2)
Return of Allotment of Shares
05/05/2009
88(2)
Return of Allotment of Shares
05/05/2009
88(2)
Return of Allotment of Shares
05/05/2009
88(2)
Return of Allotment of Shares
05/05/2009
88(2)
Return of Allotment of Shares
05/05/2009
88(2)
Return of Allotment of Shares
05/05/2009
88(2)
Return of Allotment of Shares
05/05/2009
88(2)
Return of Allotment of Shares
05/05/2009
88(2)
Return of Allotment of Shares
05/05/2009
88(2)
Return of Allotment of Shares
17/04/2009
AA
Group of companies' accounts made up to 31/12/08
07/04/2009
288c
Director's Change of Particulars
06/04/2009
88(2)
Return of Allotment of Shares


 
3.   Documents filed with the Securities and Exchange Commission ("SEC")
 
The Company submitted filings to the SEC in compliance with its obligations under national laws and rules dealing with the regulation of securities, issuers of securities and securities markets  by virtue of having American Depository Shares admitted to trading on the New York Stock Exchange. Full details of these filings can be found on the SEC's website at
www.sec.gov
.
                    
4.   Documents sent to shareholders
 
The following documents were published and sent to shareholders. They are available on the Company's website.
 

Date of Publication
Document
25/02/2010
Annual Report and Accounts
16/03/2010
Notice of Annual General Meeting


 
A copy of this Annual Information Update and copies of the documents referred to in it can be obtained from the Deputy Company Secretary at the Company's registered office:
 
Victoria Whyte
Deputy Company Secretary
GlaxoSmithKline plc
980 Great West Road
Brentford
Middlesex
TW8 9GS
 
Tel: 020 8047 5000

 

SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
 

GlaxoSmithKline plc
(Registrant)
 
 

Date: March 25, 2010

By: VICTORIA WHYTE

------------------

Victoria Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc